Polygenic Risk Score Predicts Prostate Cancer Risk Independent of Type 2 Diabetes
Diabetes, Obesity and Metabolism · 2026-06 · 28 (6) · 4991-5000
DOI: 10.1111/dom.70690 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 26.03.2026. Verfasst von Guk Jin Lee und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medical Oncology, Department of Internal Medicine, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Se…. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Diabetes Mellitus, Type 2. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NHLBI NIH HHS, Ministry of Education.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aims
Type 2 diabetes mellitus (T2DM) has been inversely associated with prostate cancer (PrCa) risk. However, it remains unclear whether a polygenic risk score (PRS) for PrCa can effectively stratify risk among men with T2DM. The primary objective of this study was to assess whether a PrCa PRS predicts PrCa risk independently of T2DM status. The secondary objective was to evaluate potential mediating factors, including insulin‐like growth factor‐1 (IGF‐1) and sex hormones. Materials and Methods We analysed data from over 140 000 men in the UK Biobank and Penn Medicine Biobank. A PrCa PRS was constructed using summary statistics from a large‐scale genome‐wide association study. Cox proportional hazards models were used to evaluate the association between PRS and incident PrCa, adjusting for relevant covariates and testing for interaction by T2DM status. Additionally, sex hormones and IGF‐1 levels were analysed to explore potential mediators.
Results
T2DM was associated with a reduced incidence of PrCa. The PrCa PRS was significantly associated with PrCa risk regardless of T2DM status ( p < 0.001), and men in the highest PRS category exhibited the greatest risk, especially among those without T2DM. IGF‐1 levels were positively associated with PrCa risk among both diabetic and non‐diabetic men, while sex hormone levels showed no significant association in men with T2DM. Adjusting for testosterone and IGF‐1 did not attenuate the association between PRS and PrCa.
Conclusions
PrCa PRS effectively stratifies risk among men with and without T2DM, highlighting the independent contribution of genetic susceptibility. Lower IGF‐1 levels in T2DM patients may partly mediate the reduced PrCa risk, suggesting a possible biological mechanism underlying these observations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Medical Oncology, Department of Internal Medicine, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
- Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Department of Medical Informatics, Kangwon National University College of Medicine, Chuncheon, Republic of Korea.
- Interdisciplinary Graduate Program in Medical Bigdata Convergence, Kangwon National University, Chuncheon, Republic of Korea.
- Division of Rheumatology, Department of Internal Medicine, Kangwon National University College of Medicine, Chuncheon, Republic of Korea.
- Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
ORCID-Profile: Guk Jin Lee, Sang-Hyuk Jung, Jae-Seung Yun, Dokyoon Kim
Förderung
- NIGMS NIH HHS
- NHLBI NIH HHS
- Ministry of Education
- Ministry of Health and Welfare, Republic of Korea
- National Institutes of Health
Zitieren
APA
Lee, G. J., Jung, S. H., Lee, J., Moon, K. W., Penn Medicine Biobank, Yun, J. S., & Kim, D. (2026). Polygenic Risk Score Predicts Prostate Cancer Risk Independent of Type 2 Diabetes. Diabetes, Obesity and Metabolism, 28(6), 4991-5000. https://doi.org/10.1111/dom.70690
Vancouver
Lee GJ, Jung SH, Lee J, Moon KW, Penn Medicine Biobank, Yun JS, et al. Polygenic Risk Score Predicts Prostate Cancer Risk Independent of Type 2 Diabetes. Diabetes, Obesity and Metabolism. 2026;28(6):4991-5000. doi:10.1111/dom.70690
BibTeX
@article{Lee2026,
author = {Lee, Guk Jin and Jung, Sang-Hyuk and Lee, Jonghyun and Moon, Ki Won and Penn Medicine Biobank, Penn Medicine Biobank and Yun, Jae-Seung and Kim, Dokyoon},
title = {Polygenic Risk Score Predicts Prostate Cancer Risk Independent of Type 2 Diabetes},
journal = {Diabetes, Obesity and Metabolism},
year = {2026},
volume = {28},
number = {6},
pages = {4991--5000},
doi = {10.1111/dom.70690}
}
EUVIMED